Related references
Note: Only part of the references are listed.Novel activating BRAF fusion identifies a recurrent alternative mechanism for ERK activation in pediatric Langerhans cell histiocytosis
Sara Zarnegar et al.
PEDIATRIC BLOOD & CANCER (2018)
Single-agent dabrafenib for BRAFV600E-mutated histiocytosis
Ankush Bhatia et al.
HAEMATOLOGICA (2018)
Single-agent dabrafenib for BRAFV600E-mutated histiocytosis
Ankush Bhatia et al.
HAEMATOLOGICA (2018)
Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study
Eli L. Diamond et al.
JAMA ONCOLOGY (2018)
New somatic BRAF splicing mutation in Langerhans cell histiocytosis
Sebastien Heritier et al.
MOLECULAR CANCER (2017)
Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study
Abdellatif Tazi et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Circulating cell-free BRAFV600E as a biomarker in children with Langerhans cell histiocytosis
Sebastien Heritier et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells
Benjamin H. Durham et al.
BLOOD (2017)
Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults
Paul Milne et al.
BLOOD (2017)
Real-time genomic profiling of histiocytoses identifies early-kinase domain BRAF alterations while improving treatment outcomes
Lynn H. Lee et al.
JCI INSIGHT (2017)
Cooperation of BRAFF595L and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signaling
M. Kordes et al.
LEUKEMIA (2016)
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms
Eli L. Diamond et al.
CANCER DISCOVERY (2016)
Hydroxyurea: a new old therapy for Langerhans cell histiocytosis
Daniel J. Zinn et al.
BLOOD (2016)
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
J.-F. Emile et al.
BLOOD (2016)
Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis
Rikhia Chakraborty et al.
BLOOD (2016)
BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy
Sebastien Heritier et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Comparison of vindesine and prednisone and cyclophosphamide, etoposide, vindesine, and prednisone as first-line treatment for adult Langerhans cell histiocytosis: A single-center retrospective study
M. -H. Duan et al.
LEUKEMIA RESEARCH (2016)
Common cancer-associated PIK3CA activating mutations rarely occur in Langerhans cell histiocytosis
Sebastien Heritier et al.
BLOOD (2015)
High efficacy of the MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis, a 20 year experience
Enrico Derenzini et al.
BMC CANCER (2015)
MAP2K1 and MAP3K1 Mutations in Langerhans Cell Histiocytosis
David S. Nelson et al.
GENES CHROMOSOMES & CANCER (2015)
Genomic Alterations in Langerhans Cell Histiocytosis
Barrett J. Rollins
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2015)
The natural history of adult pulmonary Langerhans cell histiocytosis: a prospective multicentre study
Abdellatif Tazi et al.
ORPHANET JOURNAL OF RARE DISEASES (2015)
BRAF V600E Expression in Langerhans Cell Histiocytosis Clinical and Immunohistochemical Study on 25 Pulmonary and 54 Extrapulmonary Cases
Anja C. Roden et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Somatic activating ARAF mutations in Langerhans cell histiocytosis
David S. Nelson et al.
BLOOD (2014)
High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis
Noah A. Brown et al.
BLOOD (2014)
The BRAF-V600E mutation in circulating cell-free DNA is a promising biomarker of high-risk adult Langerhans cell histiocytosis
Masayuki Kobayashi et al.
BLOOD (2014)
Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis
Rikhia Chakraborty et al.
BLOOD (2014)
Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation
Baptiste Hervier et al.
BLOOD (2014)
Frequent detection of BRAFV600E mutations in histiocytic and dendritic cell neoplasms
Heounjeong Go et al.
HISTOPATHOLOGY (2014)
BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups
Marie-Luise Berres et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis
Vincent Grobost et al.
ORPHANET JOURNAL OF RARE DISEASES (2014)
Hematopoietic Stem Cell Origin of BRAFV600E Mutations in Hairy Cell Leukemia
Stephen S. Chung et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation
Julien Haroche et al.
BLOOD (2013)
Therapeutic outcome of multifocal Langerhans cell histiocytosis in adults treated with the Special C regimen formulated by the Japan LCH Study Group
Akira Morimoto et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2013)
High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses
Julien Haroche et al.
BLOOD (2012)
B-RAF Mutant Alleles Associated with Langerhans Cell Histiocytosis, a Granulomatous Pediatric Disease
Takeshi Satoh et al.
PLOS ONE (2012)
Optimal Therapy for Adults with Langerhans Cell Histiocytosis Bone Lesions
Maria A. Cantu et al.
PLOS ONE (2012)
Treatment of patients with hypothalamic-pituitary lesions as adult-onset Langerhans cell histiocytosis
Shinsaku Imashuku et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
Treatment of Langerhans cell histiocytosis bone lesions with zoledronic acid: a case series
Shanthi Sivendran et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
BRAF Mutations in Hairy-Cell Leukemia
Enrico Tiacci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Efficacy of vinblastine in central nervous system Langerhans cell histiocytosis: a nationwide retrospective study
Sophie Ng Wing Tin et al.
ORPHANET JOURNAL OF RARE DISEASES (2011)
Recurrent BRAF mutations in Langerhans cell histiocytosis
Gayane Badalian-Very et al.
BLOOD (2010)
Response of Histiocytoses to Imatinib Mesylate: Fire to Ashes
Filip Janku et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Cell-Specific Gene Expression in Langerhans Cell Histiocytosis Lesions Reveals a Distinct Profile Compared with Epidermal Langerhans Cells
Carl E. Allen et al.
JOURNAL OF IMMUNOLOGY (2010)
Langerhans Cell Histiocytosis: Treatment Failure With Imatinib
Christina Wagner et al.
ARCHIVES OF DERMATOLOGY (2009)
Progressive diffuse pulmonary Langerhans cell histiocytosis improved by cladribine chemotherapy
R. Lazor et al.
THORAX (2009)
Cutaneous Langerhans cell histiocytosis in an elderly man successfully treated with narrowband ultraviolet B
S. Imafuku et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Sustained remission in an adult patient with Langerhans cell histiocytosis following T-cell depleted allogenic cell transplantation
Blanca Xicoy et al.
MEDICINA CLINICA (2006)
Reduced-intensity conditioned allogeneic haematopoietic transplantation in an adult with Langerhans cell histiocytosis and thrombocytopenia with absent radii
W Ingram et al.
BONE MARROW TRANSPLANTATION (2006)
Lung transplantation for pulmonary Langerhans' cell histiocytosis:: A multicenter analysis
G Dauriat et al.
TRANSPLANTATION (2006)
Imatinib mesylate for cerebral Langerhans'-cell histiocytosis
L Montella et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults.
R Vassallo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Consensus guidelines for radiation therapy of benign diseases: A multicenter approach in Germany
O Micke et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Pamidronate for bone pain from osteolytic lesions in Langerhans'-cell histiocytosis
K Arzoo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Successful treatment of cutaneous Langerhans cell histiocytosis with low-dose methotrexate
AE Steen et al.
BRITISH JOURNAL OF DERMATOLOGY (2001)
Pulmonary Langerhans' cell histiocytosis - Molecular analysis of clonality
SA Yousem et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2001)
Treatment of Langerhans cell histiocytosis with pamidronate
RP Farran et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2001)
Long term follow up of topical mustine treatment for cutaneous Langerhans cell histiocytosis
PH Hoeger et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2000)
Share Paper
